Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/86849
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Monitoring physical health and adverse effects in children and adolescents prescribed antipsychotics |
Author: | Grzeskowiak, L. Ellis, D. Phillips, A. Angley, M. |
Citation: | Journal of Pharmacy Practice and Research, 2008; 38(1):9-13 |
Publisher: | RMIT Publishing |
Issue Date: | 2008 |
ISSN: | 1445-937X 2055-2335 |
Statement of Responsibility: | Luke E Grzeskowiak, David P Ellis, Adam J Phillips, Manya T Angley |
Abstract: | Background: The adverse effects and long-term health risks associated with antipsychotic use means that monitoring children and adolescents prescribed these medications is important. Aim: To implement an evidence-based chart and guideline to monitor physical health and adverse effects in children and adolescents prescribed antipsychotics in a range of practice settings; and to identify the barriers and benefits of implementation. Method: Using an action research approach a pilot trial was undertaken to implement a chart and guideline in a range of practice settings. Patient and health professional resource kits and an information compact disc were produced to facilitate implementation. Barriers identified during implementation were doctor/health professional, patient-related and environmental. Carer and doctor satisfaction questionnaires were administered to assess the implementation process and evaluate the quality and usefulness of the monitoring chart and guideline. Results: 10 doctors were recruited to participate in the implementation trial and 21 patients prescribed antipsychotics were enrolled. Monitoring data collected retrospectively from patients' case notes, such as weight/height measurements and haematological monitoring were congruent with the guideline in 41% and 29% of patients respectively. Carer and doctor satisfaction questionnaires indicated that the monitoring package was well received and raised awareness of potential adverse effects and the importance of monitoring. Conclusion: The monitoring package can bridge the evidence to practice gap regarding monitoring physical health and adverse effects in children and adolescents prescribed antipsychotics. |
Rights: | Copyright status unknown |
DOI: | 10.1002/j.2055-2335.2008.tb00787.x |
Published version: | http://search.informit.com.au/documentSummary;dn=575789798843927;res=IELHEA |
Appears in Collections: | Aurora harvest 7 Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.